Position in PRME
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$53,837
-$6,158 QoQ
Shares Held
14,590
-15.4% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#129
of 186 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PRME Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026THOMPSON DAVIS & CO., INC. holds $146,062 across 2 Biotechnology names. PRME ranks #2 (36.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRVO |
CervoMed Inc.
|
29,750 | $92,225 | |
| 2 | PRME |
Prime Medicine, Inc.
This page
|
14,590 | $53,837 |
All Filings in PRME
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $53,837 | 14,590 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $59,995 | 17,240 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $78,907 | 22,740 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $152,754 | 27,573 | Shares | Sole | 2025-11-05 | |
| No filing history on record for this holder in this stock. | ||||||